CBDA Isolate

CBDA Isolate – Bulk and Wholesale

CBDA Isolate is a 99%+ pure crystalline cannabidiolic acid (CBDA) powder — the acidic precursor cannabinoid that decarboxylates to CBD when exposed to heat, time, or light. Unlike CBD isolate, which has already undergone decarboxylation during processing, CBDA isolate retains the carboxylic acid group on the cannabinoid structure (the -COOH functional group), making it structurally and pharmacologically distinct from its decarboxylated counterpart. CBDA exists in raw, unheated hemp as the dominant non-acidic precursor cannabinoid before sun, heat, or curing time converts it to CBD. CBDA isolate is sourced by manufacturers building raw-cannabinoid product programs, cold-process formulations, and finished products positioned around the unheated/uncured cannabinoid narrative. Available in bulk and wholesale quantities from 100 grams through 100+ kilogram tiers with significantly reduced pricing at higher volume. Material is produced in cGMP-compliant facilities and third-party tested through ISO 17025-accredited laboratories. Federally compliant under the 2018 Farm Bill at ≤0.3% Delta-9 THC by dry weight, with most batches testing at non-detect THC.

Product Specifications

• Product Type: Hemp-derived cannabidiolic acid (CBDA) isolate
• Primary Cannabinoid: Cannabidiolic Acid (CBDA)
• Chemical Formula: C₂₂H₃₀O₄
• Molecular Weight: 358.47 g/mol
• CAS Number: 1244-58-2
• Distinctive Feature: Acidic precursor to CBD; decarboxylates to CBD with heat exposure (~120°C / 248°F)
• Form / Appearance: White to off-white crystalline powder
• CBDA Purity: Typically 99%+ (batch-dependent, see COA)
• Delta-9 THC Content: Non-detect to ≤0.3% by dry weight (typically non-detect on COA)
• Solubility: Insoluble in water; soluble in ethanol, MCT oil, and lipid carriers
• Decarboxylation Threshold: ~120°C / 248°F (CBDA → CBD)
• Source: USA-grown licensed hemp
• Available Sizes: 100g, 250g, 500g, 1kg, 5kg, 10kg, 25kg, 50kg, 100kg+
• Storage: Cool, dry, light-protected (refrigeration recommended — see Storage and Handling)
• Typical Shelf Life: 12 months sealed under refrigerated conditions; less under ambient conditions
• Lead Time: 1–3 business days for in-stock inventory; longer for custom volumes

What Is CBDA?

CBDA, short for cannabidiolic acid, is the acidic precursor cannabinoid to CBD. With molecular formula C₂₂H₃₀O₄ and molecular weight 358.47 g/mol, CBDA differs from CBD (C₂₁H₃₀O₂, MW 314.46) by a carboxylic acid group (-COOH) attached to the cannabinoid ring structure. In raw, unheated hemp, CBDA is the dominant non-acidic precursor cannabinoid — CBDA converts to CBD through decarboxylation, a reaction that removes the carboxylic acid group as carbon dioxide, triggered by heat (above approximately 120°C / 248°F), prolonged sun exposure, or extended aging. This means standard hemp products that have been heated, dried, or processed contain mostly CBD; raw, unheated, or carefully-preserved hemp retains its CBDA content. CBDA isolate captures the cannabinoid in its acidic precursor form, allowing manufacturers to incorporate CBDA into finished products without having it convert to CBD during processing. The carboxylic acid group in CBDA produces a structurally and pharmacologically distinct molecule from CBD, with different cannabinoid interaction characteristics — making CBDA a meaningful differentiation cannabinoid rather than a simple CBD substitute.

How CBDA Isolate Is Produced

1. Source Material. USA-grown licensed hemp meeting Farm Bill cultivation standards (≤0.3% Delta-9 THC by dry weight at harvest). For CBDA production specifically, hemp biomass is processed quickly after harvest using cold-process methods to preserve the acidic precursor cannabinoid content before natural decarboxylation reduces CBDA levels.

2. Cold Extraction. Cannabinoids are extracted using cold-process CO₂ or cold ethanol methods, with strict temperature control to prevent decarboxylation during processing. Standard heat-driven extraction methods would convert CBDA to CBD, defeating the purpose of CBDA isolate production.

3. Cold Winterization. Cold ethanol filtration at sub-zero temperatures removes fats, waxes, and lipids while preserving the CBDA structure.

4. Selective Distillation. Specialized low-temperature distillation methods concentrate the CBDA fraction while staying below the decarboxylation threshold. This requires more careful process control than standard CBD distillation since the temperature window for distilling CBDA without converting it to CBD is narrow.

5. Crystallization. The CBDA fraction undergoes crystallization to produce 99%+ pure CBDA crystals. Recrystallization steps may be performed to achieve maximum purity.

6. Drying and Milling. Crystals are carefully dried under controlled conditions and milled to a uniform crystalline powder.

7. Compliance Verification and QA. Every batch undergoes ISO 17025-accredited third-party testing verifying CBDA purity, residual CBD content (often present from minor decarboxylation during processing), Delta-9 compliance, and absence of pesticides, heavy metals, residual solvents, mycotoxins, and microbial contamination.

Manufacturing Applications

Raw and Cold-Process Tinctures (Primary Application). CBDA isolate is the primary cannabinoid in raw-cannabinoid tinctures positioned around the unheated/uncured cannabinoid narrative. Typical concentrations: 10–50 mg/mL CBDA in carrier oils. Cold-process formulation methods are used to avoid decarboxylation during manufacturing.

Cold-Process Soft Gels and Capsules. Used in soft gels and capsules manufactured under cold-process conditions. Typical doses: 5–25 mg CBDA per soft gel, often combined with CBD.

Raw Functional Beverages. Used in cold-fill functional beverages and shots positioned around raw-cannabinoid content. Water-soluble formulations require additional emulsification given CBDA's lipid-soluble nature.

Topical and Skincare Formulations. Used in topical balms, salves, and skincare formulations where the heat profile of finished-product manufacturing stays below the decarboxylation threshold. Typical concentrations: 0.5–2% CBDA by weight.

Multi-Cannabinoid Acidic Precursor Products. Used in specialty SKUs combining CBDA with CBGA and THCA in multi-acidic-cannabinoid products positioned around the unheated cannabinoid narrative.

Pet Product Programs. Used in pet tinctures and treats targeting the raw-cannabinoid market segment in companion animal products.

Research and Development Applications. Used by formulators evaluating acidic precursor cannabinoid behavior and developing differentiated product programs. Used by analytical laboratories as reference material for cannabinoid potency testing.

Hemp-Derived Premium Edible Programs. Used in cold-process gummies and edible products manufactured under temperature-controlled conditions to preserve CBDA content.

Quality Standards and Third-Party Lab Testing

CBDA Isolate is sourced from suppliers operating cGMP-compliant production facilities equipped for cold-process cannabinoid extraction and refinement, with finished material independently tested through ISO 17025-accredited third-party laboratories. Every batch ships with a Certificate of Analysis verifying CBDA purity (typically 99%+), residual CBD content (a measure of production-process decarboxylation), Delta-9 THC compliance below the 0.3% federal threshold, and absence of pesticides, heavy metals, residual solvents, mycotoxins, and microbial contamination. Batch-specific COAs are available for buyer review prior to purchase.

Compliance and Regulatory Considerations

CBDA Isolate is produced from USA-grown hemp meeting the 2018 Farm Bill cultivation definition and is federally compliant on Delta-9 THC content. As a non-THC cannabinoid that does not convert to THC under any standard finished-product processing conditions (decarboxylation produces CBD, not THC), CBDA generally faces standard hemp regulatory treatment at the state level. Buyers are responsible for verifying state-level cannabinoid product registration and labeling requirements applicable to their finished products. CBDA's status as the acidic precursor to CBD does not create additional regulatory complexity beyond standard CBD products.

Storage and Handling

CBDA Isolate requires more careful storage than standard CBD isolate due to its temperature-sensitive nature. Store in a cool, dry environment at refrigerated temperatures (2–8°C / 36–46°F), protected from direct light and air. Ambient room-temperature storage accelerates decarboxylation and should be avoided for long-term inventory. Sealed original packaging in opaque, airtight containers preserves CBDA content. Once a container is opened, CBDA degradation accelerates — transfer unused material to airtight, light-protective storage immediately. Avoid exposure to temperatures above 30°C (86°F) at any point in the supply chain. Typical shelf life is 12 months under refrigerated conditions; significantly less under ambient conditions due to gradual decarboxylation.

Bulk and Wholesale Volume Tiers

CBDA Isolate is available in 100g, 250g, 500g, 1kg, 5kg, 10kg, 25kg, 50kg, and 100kg+ configurations. Premium pricing reflects the cold-process production infrastructure required for commercial CBDA isolate production — temperature-controlled extraction, low-temperature distillation, and refrigerated post-production handling all add cost compared to standard CBD isolate. Standing-order arrangements are available for buyers with recurring volume needs across raw-cannabinoid product programs.

Wholesale Buyers and Procurement Profiles

CBDA Isolate is sourced by manufacturers building raw-cannabinoid product lines positioned around the unheated/uncured cannabinoid narrative, by tincture producers building cold-process raw-cannabinoid SKUs (the largest single application), by formulators developing acidic-precursor multi-cannabinoid products combining CBDA with CBGA and THCA, by topical and skincare manufacturers seeking acidic-cannabinoid differentiation, by cold-fill beverage producers incorporating CBDA into raw-positioned drink formats, by pet product manufacturers building raw-cannabinoid pet programs, and by analytical laboratories sourcing CBDA isolate as reference material for cannabinoid potency testing methods.

Submit an order request through the contact form on this page or call (303) 339-0343 for current pricing, COA documentation, and available volume.